Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sarva Bio Remed is a private U.S. environmental biotechnology company that develops and manufactures proprietary bioremediation products for cleanup of hydrocarbon contamination rather than a human therapeutics biotech. Its products are used to remediate fuel oil spills in soil and water, mitigate fuel oil fumes, treat oily wastewater and bilge water, and support open-water and shoreline oil spill response. The company describes its technology base as patented biodispersion and markets multiple commercial products including VaporRemed, SpillRemed (Industrial), SpillRemed (Marine), AgroRemed, BilgeRemed, and HydroRemed. Sarva Bio Remed positions its offerings as non-toxic, organic, in situ remediation solutions for industrial, residential, marine, and environmental cleanup applications. The company appears to operate as an active small private manufacturer headquartered in York, Pennsylvania.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sarva Bio Remed.